Dolby Laboratories Common Stock (DLB)
EBITDA Growth
-11.40%
Quarterly · Period ending:
DLB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.40%period ending
Latest reported-11.40%period ending
DLB Quarterly EBITDA YoY % (36.22% → -11.40%)
Year-over-year change
High-resolution chart · PNG
DLB ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -11.396% | |
| 1.2912% | |
| -7.8338% | |
| -28.219% | |
| 0.1667% | |
| 1.5099% | |
| 9.2885% | |
| 152.6795% | |
| 48.5009% | |
| 0.4603% | |
| -16.7977% | |
| -37.8257% | |
| -37.312% | |
| 103.2113% | |
| 2.9286% | |
| -37.0926% | |
| -11.5037% | |
| -39.2607% | |
| -38.5162% | |
| 38.462% | |
| 36.0507% | |
| -12.0916% | |
| 158.8248% | |
| -21.7528% | |
| -0.2163% | |
| -0.0153% | |
| -20.7779% | |
| 108.1721% | |
| 328.1162% | |
| 20.4339% | |
| -19.021% | |
| -18.4149% | |
| -87.2364% | |
| 22.7701% | |
| 30.0999% | |
| -11.2782% | |
| 13.7014% | |
| -16.7294% | |
| 45.9259% | |
| -35.0484% | |
| 58.9083% | |
| 9.5328% | |
| -13.3995% | |
| 11.236% | |
| -0.9471% | |
| -16.2651% | |
| -7.3538% | |
| -0.4854% | |
| 14.3824% | |
| 17.492% | |
| -4.6457% | |
| -13.8913% | |
| -25.7609% | |
| -25.0861% | |
| -27.1575% | |
| -35.3789% | |
| -25.4995% | |
| 1.2458% | |
| -7.0918% | |
| 14.4409% | |
| -3.6352% | |
| -9.5911% | |
| 7.5412% | |
| 57.6658% | |
| 36.5716% | |
| 21.7458% | |
| -9.9964% | |
| 2.225% | |
| 5.5413% | |
| 1,588.5584% | |
| 67.9393% | |
| 27.3335% | |
| 70.1923% | |
| -86.646% | |
| 96.6058% | |
| 14.047% | |
| 65.2264% | |
| 31.2914% | |
| 55.8185% | |
| 81.3914% | |
| 0.5559% | |
| 98.4178% | |
| 31.1897% | |
| 139.7519% | |
| -43.7235% | |
| -59.6227% | |
| -53.7769% | |
| -55.7394% | |
| 52.1304% | |
| 51.6281% | |
| 36.2168% |